| Seizure disorder | Autoimmune conditions | Allergic rhinitis | Asthma | Ab deficiency |
---|
ASD
c
subjects
| Â | Â | Â | Atopic | Non-atopic | Â |
ASD-IS (N = 24) | 4/24 | 2/24a
| 2/24 | 0 | 3/24 | 3/24b
|
ASD/NFA (N = 20) | 2/20 | 0 | 3/20 | 1/20 | 0 | 0 |
ASD/non-NFA (N = 20) | 1/20 | 0 | 0 | 0 | 0 | 0 |
Non-ASD subjects
| Â | Â | Â | Â | Â | Â |
Non-ASD/NFA (N = 16) | 0 | 0 | 0 | 0 | 0 | 0 |
Normal control (N = 16) | 0 | 0 | 3/16 | 1/16 | 1/16 | 0 |
PANS (N = 18) | 0 | 0 | 3/18 | 0 | 0 | 2/18 |
-
aOne subject was diagnosed with psoriasis and another subject was diagnosed with anti-phospholipid syndrome.
-
bAll subjects diagnosed with antibody deficiency syndrome were on IVIG treatment at the time of sample obtainment. All the subjects were shown to have severely impaired responses to Pneumovax’.
-
c
Abbreviations used; Ab, antibody; ASD, autism spectrum disorder; ASD-IS, ASD-inflammatory subtype; NFA, non-IgE mediated food allergy; PANS, pediatric acute onset neuropsychiatric syndrome.